Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.

AusPAR: Febuxostat (FBX)

Australian Public Assessment Report

AusPAR

AusPAR: Febuxostat (FBX) [PDF, 823.72 KB]

AusPAR: Febuxostat (FBX) [Word, 542.16 KB]

Attachment: Product information: Febuxostat (FBX) [PDF, 300.45 KB]

Attachment: Product information: Febuxostat (FBX) [Word, 74.7 KB]

Attachment: Extract from the Clinical Evaluation Report: Febuxostat (FBX) [PDF, 854.76 KB]

Attachment: Extract from the Clinical Evaluation Report: Febuxostat (FBX) [Word, 472.06 KB]

Device/Product Name

Adenuric

Active ingredients

Febuxostat (FBX)

AusPAR Date

8 January 2015

Published

25 February 2015

Submission Number

PM-2012-03425-1-3

Submission Type

New chemical entity

Decision

Approved